Navigation Links
Jon R. Wampler Joins Portico Systems' Board of Directors
Date:9/18/2007

locking the value of Provider Network Management. Our hallmark Portico Provider Platform empowers health plans to infuse agility into their provider network management functions while delivering actionable provider information. The platform streamlines provider network processes while accelerating new revenue streams, enhancing employee effectiveness and optimizing provider relationships. For more information, please contact Chris Jones at cjones@porticosys.com or 215-358-3723. You may also visit our website at http://www.porticosys.com.

About Safeguard

Safeguard Scientifics, Inc. (NYSE: SFE) builds value in high-growth, revenue-stage information technology and life sciences businesses. Safeguard provides growth capital as well as a range of strategic, operational and management resources to our partner companies. Safeguard participates in expansion financings, corporate spin-outs, management buyouts, recapitalizations, industry consolidations and early-stage financings. http://www.safeguard.com


'/>"/>
SOURCE Portico Systems
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Ranbaxy joins hand with Cipla to co-market ciprofloxacin
2. Rat joins list of cloned animals
3. Richard Gere Joins Indian Stars For Fight Against AIDS
4. Enbrel Joins with Methotrexate to Cure Rheumatoid Arthritis
5. Anoushka Joins Hands With WFP to Feed the Poor
6. India Joins Hands With Global Body for Vaccine Research
7. Another Statewide Organization Joins the Fight Against Assisted Suicide
8. Two-year-old Joins Mensa, Becomes Its Youngest Ever Genius
9. New Computerized Imaging Systems Help In Better Dental Treatment Planning
10. Painkilling Patch As Effective As Intravenous Delivery Systems
11. WHO says damage to eco systems are affecting human health
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 2BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 3BioCryst Pharmaceuticals Elects Charles A. Sanders to its Board of Directors 4Shanghai ChemPartner Is Pleased to be Part of Agios' Groundbreaking Cancer Research 2Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 2Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 3Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 4Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 5Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 6Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 7Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 8Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 9Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 10Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 11Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 12Helix BioPharma Corp. Announces Fiscal Q1 2010 Results 13Immune responses to flu vaccine are diminished in lupus patients 53173 1Immune responses to flu vaccine are diminished in lupus patients 53173 2Nanoparticle delivered suicide genes slowed ovarian tumor growth 9423 1Nanoparticle delivered suicide genes slowed ovarian tumor growth 9423 2Reducing risk of hospitalization in the elderly 9421 1Reducing risk of hospitalization in the elderly 9421 2